FDA Inspection
American National Red CrossAmerican National Red Cross – FDA Inspection, Nov 8, 2017
Record Details
This FDA Inspection record concerns American National Red Cross, with an inspection on November 8, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 0a86f4aa-02b2-486a-b6aa-a9cfd7d1297c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031265
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 630.15(b)(2)(iii)Donor consent clear
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American National Red Cross
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 27, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 21, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 21, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 22, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 9, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American National Red Cross
- FDA Inspection 1331258 - 2026-07-27
- FDA Inspection 1154951 - 2021-09-21
- FDA Inspection 939360 - 2015-08-21
- FDA Inspection 845926 - 2013-08-22
- FDA Inspection 753754 - 2011-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.